NCT01441869 - Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin

Interventions

DRUG

Onglyza (saxagliptin)

Oral tablets, 5 mg , single dose

DRUG

Diabex

Extended release oral tablets, 1000 mg, single dose

DRUG

5-mg saxagliptin/1000 mg metformin

Extended release fixed dose combination tablet, single dose

DRUG

Diabex

Extended release oral tablets, 500 mg, single dose

DRUG

5-mg saxagliptin/500 mg metformin

Extended release fixed dose combination tablet, single dose

Trial Locations (1)

Research Site, Overland Park